De novo developed protein binders mimicking Interferon lambda signaling

FEBS J. 2022 May;289(9):2672-2684. doi: 10.1111/febs.16300. Epub 2021 Dec 7.

Abstract

We hereby describe the process of design and selection of nonantibody protein binders mimicking cytokine signaling. We chose to mimic signaling of IFN-λ1, type 3 interferon (also known as IL-29) for its novelty and the importance of its biological functions. All four known interferons λ signal through binding to the extracellular domains of IL-28 receptor 1 (IL-28R1) and IL-10 receptor 2 (IL-10R2). Our binders were therefore trained to bind both receptors simultaneously. The bifunctional binder molecules were developed by yeast display, a method of directed evolution. The signaling capacity of the bivalent binders was tested by measuring phosphorylation of the JAK/STAT signaling pathway and production of mRNA of six selected genes naturally induced by IFN- λ1 in human cell lines. The newly developed bivalent binders offer opportunities to study cytokine-related biological functions and modulation of the cell behavior by receptor activation on the cell surfaces alternative to the use of natural IFN-λ.

Keywords: IFN-λ; IL-29; cytokine signaling; cytokines; directed evolution; interferon lambda; protein scaffolds; yeast display.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / metabolism
  • Cytokines / metabolism
  • Humans
  • Interferons* / metabolism
  • Interleukins* / metabolism
  • Signal Transduction

Substances

  • Antiviral Agents
  • Cytokines
  • Interleukins
  • Interferons